After a slow start for the week, the S&P 500 gained 0.6% while the Nasdaq Composite gained 1.4% and the Dow Jones increased by .3%. As you would expect, quarterly
earnings were a big factor in driving the markets this week - more results will be released in coming
weeks with 75% of S&P 500 members still due to report their earnings. Thus
far, this earnings season has delivered some good surprises.
One company with a
great earnings report was Johnson & Johnson (JNJ). The company beat both revenue and earnings estimates
for the quarter, helping the momentum in U.S. stocks and the healthcare
industry. For the quarter, their revenue was $18.48 billion, beating analysts average
estimate by $500 million. Earnings for
the second quarter were $1.74, 6 cents more than the analysts predicted.
With their great earnings
report, ETFs that have a exposure to Johnson and Johnson also lead the way this
week. The 2 ETFs that have the biggest exposure to Johnson & Johnson,
XLV, Health Care Select Sector SPDR Fund, and CURE, Direxion Daily HealthCare, gained 2% and 4% respectively this week.
Global equities seemed to also do surprisingly well this week despite so many international issues and turbulence including the attempted coup in Turkey, the potential for change in monetary policy from the Bank of
Japan next week and the European Central Bank keeping all of its
interest rates unchanged on Thursday, adding that it expects rates to remain at
present or lower levels for an extended period.
In ETF news, SEC moved to expedite the approval of
exchange-traded funds run by human stock and bond pickers. This could lead to
even larger and faster growth of the already growing ETF industry. The
SEC on Friday approved
guidelines for actively managed ETFs, which aim to cut months off the process
of bringing these funds to market.
This week BWV, HOMX, PGX, and DIVC were are top 4 of biggest
gains in our Quant movers section. Each fund’s quant score increased by
16%, 12%, 12%, and 10% respectively. Our biggest losers this week were IEV,
BDCS, MLPG, MLPI. Each fund lost 12%, 10%, 10%, and 9% respectively.
This week was another steady week for our select list. However,
there was 1 unranked funds from last week that made it to the top spot in their
category, and a number 5 ranked fund that made it to number 1. They were EWU in
the European region, and XES, in the energy sector.
Thank you for reading ETF Global Perspectives!
ETFG 21 Day Free
Trial: https://www.etfg.com/signup/quick
_____________________________________________________________
Assumptions,
opinions and estimates constitute our judgment as of the date of this material
and are subject to change without notice.
ETF Global LLC (“ETFG”) and its affiliates and any third-party
providers, as well as their directors, officers, shareholders, employees or
agents (collectively ETFG Parties) do not guarantee the accuracy, completeness,
adequacy or timeliness of any information, including ratings and rankings and
are not responsible for errors and omissions or for the results obtained from
the use of such information and ETFG Parties shall have no liability for any
errors, omissions, or interruptions therein, regardless of the cause, or for
the results obtained from the use of such information. ETFG PARTIES DISCLAIM
ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO ANY
WARRANTIES OF MERCHANTABILITY, SUITABILITY OR FITNESS FOR A PARTICULAR PURPOSE
OR USE. In no event shall ETFG Parties
be liable to any party for any direct, indirect, incidental, exemplary,
compensatory, punitive, special or consequential damages, costs, expenses,
legal fees, or losses (including, without limitation, lost income or lost
profits and opportunity costs) in connection with any use of the information
contained in this document even if advised of the possibility of such damages.
ETFG
ratings and rankings are statements of opinion as of the date they are
expressed and not statements of fact or recommendations to purchase, hold, or
sell any securities or to make any investment decisions. ETFG ratings and
rankings should not be relied on when making any investment or other business
decision. ETFG’s opinions and analyses
do not address the suitability of any security.
ETFG does not act as a fiduciary or an investment advisor. While ETFG has obtained information from
sources they believe to be reliable, ETFG does not perform an audit or
undertake any duty of due diligence or independent verification of any
information it receives.
This
material is not intended as an offer or solicitation for the purchase or sale
of any security or other financial instrument. Securities, financial
instruments or strategies mentioned herein may not be suitable for all
investors. Any opinions expressed herein
are given in good faith, are subject to change without notice, and are only
correct as of the stated date of their issue.
Prices, values, or income from any securities or investments mentioned
in this report may fall against the interests of the investor and the investor
may get back less than the amount invested.
Where an investment is described as being likely to yield income, please
note that the amount of income that the investor will receive from such an
investment may fluctuate. Where an
investment or security is denominated in a different currency to the investor's
currency of reference, changes in rates of exchange may have an adverse effect
on the value, price or income of or from that investment to the investor.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.